Suchergebnisse
Suchergebnisse:
Join Apotex and discover the endless opportunities. We’d love to hear how you can contribute to our team.
Apotex Inc. is a Canadian pharmaceutical corporation. Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$2.5 billion. By 2023, Apotex employed close to 8,000 people as Canada's largest drug manufacturer, with over 300 products selling in over 115 countries.
Apotex Inc. (Dachgesellschaft: Apotex Pharmaceutical Holdings Inc.) ist ein kanadisches Pharmaunternehmen mit Hauptsitz in Toronto (Provinz Ontario). Das 1974 von Barry Sherman (1942–2017) gegründete Unternehmen ist der größte Generika-Hersteller in Händen kanadischer Eigentümer.
Products. Apotex currently produces more than 300 generic pharmaceuticals in approximately 4000 dosages. The company's pharmaceuticals can be found in virtually every pharmacy and healthcare facility in Canada and are exported to more than 100 countries around the globe.
Five Decades of Innovation. Over the last five decades, we built a core generics business driven by Our Purpose: We improve everyday access to affordable and innovative medicines and health products for patients and consumers worldwide.
We have an incredible team of bright, passionate, and committed individuals who are proudly dedicated to our mission of bringing a growing array of high quality, affordable medicines to healthcare systems in 115 countries around the globe.
Research at Apotex includes the development of generic, biosimilar and innovative pharmaceuticals. New products have been a critical component of Apotex's growth and are central to fulfilling our company’s purpose and have resulted in the development of substantial expertise in formulation development, synthetic and analytical chemistry.
